Product News
Filter News
Found 179,769 articles
-
It was reported today that U.S.-based Merck & Co. will lower the price of some of its drug. It appears to be rippling through the industry, largely in an attempt to stay out of the way of Trump’s attack-tweets.
-
Some diagnostics testing for infectious diseases can be quite invasive and uncomfortable for a patient. Now though, a new form of test is available that can mitigate the need for those invasive tests.
-
Alcon introduces NGENUITY® 3D Visualization System with DATAFUSION™ to simplify, customize vitreoretinal surgery
7/20/2018
Innovation to headline Alcon's presence at the American Society of Retina Specialists (ASRS) annual meeting
-
AVITA Medical Announces Expansion of Management Team to Support Planned U.S. Launch of RECELL® Device
7/20/2018
AVITA Medical announced that it expanded its management team in the commercial, legal and medical affairs functions to support the planned U.S. launch of the RECELL® Autologous Cell Harvesting Device in the treatment of burns.
-
Dr. Reddy’s Announces the Launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg in the U.S. Market
7/20/2018
Dr. Reddy’s Laboratories Ltd. announced the launch of Esomeprazole Magnesium Delayed-Release Capsules USP
-
Laminate Medical Technologies announces first forearm fistula cases in Germany
7/20/2018
Laminate Medical Technologies announced the first forearm fistula cases in Germany.
-
Sierra Gold Hemp Finds Explosive Growth In 2018
7/20/2018
Sierra Gold Hemp announces their successful expansion into Colorado and Nevada.
-
Roche’s Tecentriq Sees Mixed Results in Interim Phase III Lung Cancer Analysis, Study to Continue
7/19/2018
Roche’s Tecentriq, in combination with chemotherapy, hit its co-primary endpoint of progression-free survival in a Phase III trial for non-small cell lung cancer patients. But, the Swiss pharma giant said the combination has so far failed to achieve statistical significance in overall survival, a... -
Patient Death: Mersana Shares Plunge
7/19/2018
Shares of Mersana Therapeutics have plunged nearly 40 percent this morning after the company announced the FDA placed a partial clinical hold on its Phase I antibody drug conjugate XMT-1522 following the death of a patient. -
In a speech given at the Brookings Institution preceding the release of the U.S. Food and Drug Administration (FDA)’s Biosimilars Action Plan, FDA Commissioner Scott Gottlieb unloaded on big pharma.
-
Kite, a Gilead company based in Santa Monica, California, signed an agreement with Utrecht, Netherlands-based Gadeta BV. The companies will work on discovering and developing novel cancer immunotherapies based on gamma-delta T-cell receptors (TCRs).
-
Pulmonary Fibrosis Foundation Launches New PF Health App
7/19/2018
Connects Patients To Resources, Providers And Researchers
-
Companion Medical Announces CE Mark of InPen™ System
7/19/2018
Companion Medical has received CE mark for the InPen system, paving the way for launch in key international markets.
-
HAYMAN-WOODWARD: Brazilian dentists are among the most desired professionals in the US
7/19/2018
EB-1A and EB-2 NIW visa categories benefit high qualified dentists to come to America
-
New Video: Leading Breast Cancer Surgeons Talk About Improving Quality Of Care
7/19/2018
KUBTEC announced today that it has released a new video featuring top breast cancer surgeons discussing how intraoperative specimen tomosynthesis has improved quality of care for their patients.
-
Biogal-Galed Labs Announces the Commercialization of the PCRun® Canine Distemper Molecular Detection Kit
7/19/2018
Biogal Galed Lab has announced the commercialization of a new PCRun® Veterinary Molecular Detection kit, the PCRun® Canine Distemper RNA Molecular Detection Kit.
-
Nuvasive Launches MAGEC X For Early Onset Scoliosis Treatment
7/19/2018
The latest advancement of MAGEC® delivers improved rod strength together with internal rod mechanism advancements
-
IFM Therapeutics, LLC Launches Subsidiary, IFM Tre, with $31 Million Series A Financing to Develop NLRP3 Antagonists for Inflammatory Diseases
7/19/2018
Subsidiary responsible for clinical development of NLRP3 antagonist portfolio with lead candidate expected in the clinic in 2019
-
InventHelp Inventor Develops Personal Care Item for Male Urinary Incontinence (QCY-308)
7/19/2018
An inventor from Kannoplis, N.C., has developed the CONDOM CATHETER, a protective personal care item designed to provide added confidence and peace of mind for men who experience urinary incontinence.
-
ConferenceSeries offers One-of-A-Kind Experience with On-Site and Online Scientific Conferences
7/19/2018
Event organizer bringing its 10 years of healthcare communication expertise and deep knowledge of research to the scientific community